A detailed history of Kendall Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kendall Capital Management holds 19,785 shares of MRK stock, worth $1.95 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
19,785
Previous 18,955 4.38%
Holding current value
$1.95 Million
Previous $2.35 Million 4.26%
% of portfolio
0.71%
Previous 0.8%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$111.15 - $128.97 $92,254 - $107,045
830 Added 4.38%
19,785 $2.25 Million
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $130,609 - $140,272
1,055 Added 5.89%
18,955 $2.35 Million
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $82,099 - $95,663
-725 Reduced 3.89%
17,900 $2.36 Million
Q4 2023

Jan 26, 2024

SELL
$100.18 - $109.02 $40,572 - $44,153
-405 Reduced 2.13%
18,625 $2.03 Million
Q3 2023

Oct 31, 2023

SELL
$102.95 - $114.33 $11,839 - $13,147
-115 Reduced 0.6%
19,030 $1.96 Million
Q2 2023

Jul 28, 2023

BUY
$108.61 - $118.38 $49,960 - $54,454
460 Added 2.46%
19,145 $2.21 Million
Q1 2023

May 11, 2023

SELL
$102.94 - $114.86 $13,691 - $15,276
-133 Reduced 0.71%
18,685 $1.99 Million
Q4 2022

Jan 30, 2023

SELL
$87.44 - $112.11 $61,820 - $79,261
-707 Reduced 3.62%
18,818 $2.09 Million
Q3 2022

Nov 02, 2022

BUY
$84.53 - $94.96 $43,702 - $49,094
517 Added 2.72%
19,525 $1.68 Million
Q2 2022

Jul 29, 2022

BUY
$83.49 - $94.64 $31,308 - $35,490
375 Added 2.01%
19,008 $1.73 Million
Q1 2022

May 06, 2022

BUY
$73.51 - $82.4 $73,142 - $81,988
995 Added 5.64%
18,633 $1.53 Million
Q4 2021

Jan 28, 2022

BUY
$72.28 - $90.54 $101,192 - $126,756
1,400 Added 8.62%
17,638 $1.35 Million
Q3 2021

Nov 05, 2021

BUY
$71.68 - $78.83 $78,848 - $86,713
1,100 Added 7.27%
16,238 $1.22 Million
Q2 2021

Jul 30, 2021

BUY
$70.31 - $77.77 $224,640 - $248,475
3,195 Added 26.75%
15,138 $1.18 Million
Q1 2021

May 05, 2021

BUY
$68.86 - $81.11 $112,930 - $133,020
1,640 Added 15.92%
11,943 $921,000
Q4 2020

Feb 08, 2021

BUY
$71.77 - $79.65 $114,832 - $127,440
1,600 Added 18.38%
10,303 $843,000
Q3 2020

Oct 22, 2020

BUY
$73.18 - $82.95 $174,534 - $197,835
2,385 Added 37.75%
8,703 $722,000
Q2 2020

Jul 30, 2020

BUY
$70.42 - $80.13 $111,967 - $127,406
1,590 Added 33.63%
6,318 $489,000
Q1 2020

Apr 27, 2020

BUY
$63.36 - $87.82 $41,564 - $57,609
656 Added 16.11%
4,728 $364,000
Q4 2019

Jan 24, 2020

BUY
$77.58 - $87.54 $36,074 - $40,706
465 Added 12.89%
4,072 $370,000
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $69,613 - $75,880
915 Added 33.99%
3,607 $304,000
Q1 2019

May 08, 2019

SELL
$69.58 - $79.36 $27,484 - $31,347
-395 Reduced 12.8%
2,692 $224,000
Q3 2018

Oct 29, 2018

BUY
$57.69 - $67.84 $178,089 - $209,422
3,087 New
3,087 $219,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Kendall Capital Management Portfolio

Follow Kendall Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.